pyrroles has been researched along with Desmoid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hong, YS; Jo, JC; Kim, KP; Kim, SY; Kim, TW; Lee, J; Lee, JL; Lee, JS; Park, YS; Ryu, JS | 1 |
| Clohisy, DR; Frolich, JW; Manivel, JC; Skubitz, KM | 1 |
1 review(s) available for pyrroles and Desmoid
| Article | Year |
|---|---|
Response of imatinib-resistant extra-abdominal aggressive fibromatosis to sunitinib: case report and review of the literature on response to tyrosine kinase inhibitors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Benzamides; Drug Resistance, Neoplasm; Female; Fibromatosis, Aggressive; Follow-Up Studies; Humans; Imatinib Mesylate; Indoles; Neoplasm Recurrence, Local; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Sunitinib; Treatment Outcome; Young Adult | 2009 |
1 trial(s) available for pyrroles and Desmoid
| Article | Year |
|---|---|
A prospective multicenter phase II study of sunitinib in patients with advanced aggressive fibromatosis.
Topics: Adult; Aged; Angiogenesis Inhibitors; Disease-Free Survival; Female; Fibromatosis, Aggressive; Humans; Indoles; Male; Middle Aged; Pyrroles; Sunitinib; Treatment Outcome; Tumor Burden; Young Adult | 2014 |